Company Profile

  Linyi Xinghua Medical Equipment Co., Ltd., established in 2004, is a key regulatory enterprise of SFDA and is mainly engaged in R&D, production and sales of three types of medical polymer materials including main products — disposable epidural anesthesia catheter with an annual production of 10 million, accounting for 60% market share of similar products in the domestic market. Compared with developed countries, China is lagging behind in the development of medical catheters, particularly high-tech medical intervention catheters and other medical plastic products, which are virtually nonexistent.
  In view of the domestic product defects, the company has cooperated with a number of universities and research institutes to jointly develop a new generation of epidural anesthesia catheter and improve the product in technology, materials, performance and production process so that products can reach international level and be more competitive in the market.
  The company has 2000 square meters of 100,000-level purification workshop. Combined its own technology with developed system, it is dedicated to developing medical polymer products and has successfully developed a number of medical device products with independent intellectual rights. A number of projects have been included in the national R&D Projects of Science and Technology. Cooperated with a number of medical device companies, it specializes in processing and production of catheter-related accessories.
  As a member of China Medical Device Association, the company has independent import and export rights and its products are exported to Europe, the Middle East and other countries. In 2009, the company was awarded “Key Support Enterprise of State Ministry of Science and Technology”, “Advanced Scientific and Technological Innovation Enterprise in Linyi High-tech Zone” and “Linyi Contract-honoring & Credit-keeping Enterprise”.
  In the future, the company will focus on the development of medical interventional catheter, make progress towards the international markets and make unremitting efforts to relieve human suffering.